AI assistant
Sending…
ATOSSA THERAPEUTICS, INC. — Director's Dealing 2023
Nov 17, 2023
34113_dirs_2023-11-17_fd1a8c67-b19a-4a00-b365-58e2287f6844.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ATOSSA THERAPEUTICS, INC. (ATOS)
CIK: 0001488039
Period of Report: 2023-11-15
Reporting Person: WEAVER GREGORY L (Director, Former EVP, CFO, & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-15 | Common Stock | S | 50000 | $0.65 | Disposed | 55 | Direct |
More from ATOSSA THERAPEUTICS, INC.
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 16
Director's Dealing
2026
Mar 31
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 20
Capital/Financing Update
2026
Feb 20
Delisting Announcement
2026
Feb 17
Regulatory Filings
2026
Feb 11